Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
400 Leser
Artikel bewerten:
(2)

United-Guardian, Inc.: United-Guardian Reports Third Quarter Financial Results

HAUPPAUGE, N.Y., Nov. 09, 2022 (GLOBE NEWSWIRE) -- United-Guardian, Inc. (NASDAQ:UG) reported today that net income for the third quarter of 2022 decreased from $1,016,506 ($0.22 per share) in 2021 to $345,518 ($0.07 per share) in this year's third quarter. Net sales for the quarter decreased from $3,179,746 to $2,417,022. For the nine-month period ended September 30th net income decreased from $3,542,232 ($0.77 per share) in 2021 to $1,890,307 ($0.41 per share) this year, and net sales decreased from $10,268,592 to $9,935,557.

Beatriz Blanco, the company's new President and CEO, stated, "Our largest marketing partner, Ashland Specialty Ingredients, which is responsible for marketing our products in China, informed us that their sales of our products in the third quarter were adversely affected by several things, the most significant of which was the continuing impact of the coronavirus pandemic in China. They also indicated that the reduced sales that they experienced in the third quarter was exacerbated by some overstocking issues, especially in connection with one of their major customers switching from one of our Lubrajel formulations to a different one, which resulted in inventory that had to be worked off. They indicated that they are not aware of any significant loss of customers, and anticipate that sales will increase over the coming months, especially as the coronavirus situation improves in China. We remain optimistic that our sales and earnings will improve as the global economy continues to improve, and we are looking forward to a stronger 2023."

United-Guardian is a manufacturer of cosmetic ingredients, personal and health care products, pharmaceuticals, and specialty industrial products.

Contact:Investor Relations
 (631) 273-0900

NOTE: This press release contains both historical and "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements about the company's expectations or beliefs concerning future events, such as financial performance, business prospects, and similar matters, are being made in reliance upon the "safe harbor" provisions of that Act. Such statements are subject to a variety of factors that could cause our actual results or performance to differ materially from the anticipated results or performance expressed or implied by such forward-looking statements. For further information about the risks and uncertainties that may affect the company's business please refer to the company's reports and filings with the Securities and Exchange Commission.

STATEMENTS OF INCOME
FOR THE
THREE AND NINE MONTHS ENDED
SEPTEMBER 30, 2022 and 2021*
(UNAUDITED)

  THREE MONTHS ENDED
SEPTEMBER 30,
 NINE MONTHS ENDED
SEPTEMBER 30,
  2022  2021  2022  2021 
             
Net sales$2,417,022 $3,179,746 $9,935,557 $10,268,592 
             
Costs and expenses:            
Cost of sales 1,076,035  1,320,509  4,479,905  4,180,912 
Operating expenses 532,333  458,582  1,699,311  1,428,721 
Research and development 120,924  130,742  364,856  349,053 
Total costs and expenses 1,729,292  1,909,833  6,544,072  5,958,686 
Income from operations 687,730  1,269,913  3,391,485  4,309,906 
             
Other Income:            
Investment income 46,995  38,747  146,405  124,147 
Net (loss) gain on marketable securities (300,526) (25,108) (1,154,464) 40,419 
Total other (loss) income (253,531) 13,639  (1,008,059) 164,566 
Income before provisionfor income taxes
 434,199  1,283,552  2,383,426  4,474,472 
             
Provision for income taxes 88,681  267,046  493,119  932,240 
Net income$345,518 $1,016,506 $1,890,307 $3,542,232 
             
Earnings per common share            
(Basic and Diluted)$0.07 $0.22 $0.41 $0.77 
             
Weighted average shares - basic            
and diluted 4,594,319
  4,594,319
  4,594,319
  4,594,319
 

* Additional financial information can be found at the company's web site at www.u-g.com.


Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2022 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.